Salta al contenuto
Universidad del Mar SIBUMAR Descubridor Institucional UMAR
  • Inicio
  • Búsqueda avanzada
  • Explorar
  • Entra
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Avanzata
  • Real world study of pertuzumab-trastuzumab-chemotherapy versus trastuzumab-chemotherapy in neoadjuvant treatment of breast cancer
Copertina

Real world study of pertuzumab-trastuzumab-chemotherapy versus trastuzumab-chemotherapy in neoadjuvant treatment of breast cancer

Fuente: Redalyc
Salvato in:
Dettagli Bibliografici
Autore principale: Rocío Díaz-Acedo
Natura: Artículo científico
Lingua:en
Pubblicazione: Sociedad Española de Farmacia Hospitalaria 2020
Soggetti:
Medicina
Pertuzumab
Trastuzumab
Neoadjuvance
Breast cancer
Pathological complete response
Accesso online:
Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
  • Citazione
  • Invia SMS
  • Invia email
  • Stampa
  • Esporta il record
    • Esporta a RefWorks
    • Esporta a EndNoteWeb
    • Esporta a EndNote
  • Aggiungi alla lista
  • PLink permanente
  • Posseduto
  • Descrizione
  • Commenti
  • Documenti analoghi
  • MARC21

Accesso online

https://www.redalyc.org/articulo.oa?id=365964773005
https://www.redalyc.org/journal/3659/365964773005/
https://www.redalyc.org/journal/3659/365964773005/html/
https://www.redalyc.org/journal/3659/365964773005/365964773005.epub
https://www.redalyc.org/journal/3659/365964773005/movil

Documenti analoghi

  • Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study
    di: Eyyup Cavdar
    Pubblicazione: (2022)
  • Cardiotoxicity associated with trastuzumab in normal clinical practice
    di: C. Vicente
    Pubblicazione: (2009)
  • Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report
    di: Patricia Miranda Romero
    Pubblicazione: (2015)
  • Alertas de cardiotoxicidad en el tratamiento con trastuzumab en cáncer de mama, 4 años de seguimiento
    di: DANIEL A SANTOS
    Pubblicazione: (2019)
  • An economic evaluation of trastuzumab as adjuvant treatment of early HER2-positive breast cancer patients in Colombia
    di: Jefferson Antonio Buendía
    Pubblicazione: (2013)
Universidad del Mar
Universidad del MarSistema Bibliotecario de la Universidad del MarDescubridor Institucional UMARImplementación y desarrollo: Mtro. Carlos Alonso Albores Pérez
InicioBúsqueda avanzadaExplorar
Visitas al Descubridor: 387,319© 2026 Universidad del Mar